Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Use of Domperidone for Gastroparesis

NCT02227927 is registered in ClinicalTrials.gov with Scott Gabbard, MD as lead sponsor.

NCT NCT02227927
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02227927 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Use of Domperidone for Gastroparesis
Lead sponsor
Scott Gabbard, MD
Phase
Expanded access
Overall status
No longer available
Start date
Not reported
Completion date
Not reported
Enrollment
Not reported
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

gastroesophageal reflux disease, gastroparesis, gerd